142 filings
Page 7 of 8
8-K
xcge22p l8oee2d5
28 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
hqmq7
21 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
bu4u23x9sx8k
9 Mar 16
Akebia Prevails in European Patent Dispute and Preserves Access to Key Market for Vadadustat
12:00am
8-K
8ql5tz8
12 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
k4zmn
5 Jan 16
Termination of a Material Definitive Agreement
12:00am
8-K
qttpu8lq35d
4 Jan 16
Other Events
12:00am
8-K
yqn89s95oanv150
14 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
ywx cg4om74
27 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
wkoo5v3 4df
6 Oct 15
Akebia Reaches Agreement with FDA and EMA on Vadadustat Global Phase 3 Program
12:00am
8-K
ppa6mfoh 7g6w
8 Sep 15
Akebia Announces Positive Top-Line Results from its Phase 2 Study of
12:00am
8-K
jleqev vq
11 Aug 15
Akebia Announces Second Quarter 2015 Financial Results
12:00am
8-K
tzj5aillkra8 v0rwnu
15 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
l22jwgqr6 xc
11 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
5bsgxorr6
17 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
51mzpawz1f0
18 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
whjyjt71ifenp2a
27 Oct 14
Akebia Announces Positive Top-Line Results from its Phase 2b Study of
12:00am
8-K/A
unclz2yf5b fbq
22 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K/A
hjetzdoq36
22 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
h9bjj02
15 Sep 14
Akebia Therapeutics Appoints Ronald C. Renaud Jr. to its Board of Directors
12:00am
8-K
49428itoy6s70
6 Aug 14
Akebia Therapeutics Announces Expansion of Management Team
12:00am